News Search News ... All Press Release Years All Years 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 Bausch Health Completes Acquisition of DURECT Corporation, Expanding Late-stage Liver Disease Portfolio September 11, 2025 DURECT Corporation Reports Second Quarter 2025 Financial Results and Provides Update on Proposed Acquisition by Bausch Health August 12, 2025 Bausch Health to Acquire DURECT Corporation, Strengthening Commitment to Developing Innovative Solutions for Patients with Liver Disease July 29, 2025 DURECT Corporation Reports First Quarter 2025 Financial Results and Provides Business Update May 13, 2025 DURECT Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update March 26, 2025 DURECT Corporation to Announce Fourth Quarter and Full Year 2024 Financial Results and Provide a Business Update March 19, 2025 DURECT Corporation to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference February 4, 2025 DURECT Corporation Announces Publication of Larsucosterol Phase 2b Results in NEJM Evidence January 28, 2025 DURECT Corporation Announces Sale of ALZET® Product Line to Lafayette Instrument Co. for $17.5 Million November 25, 2024 DURECT Corporation Reports Third Quarter 2024 Financial Results and Provides Business Update November 13, 2024
